Friday, December 30, 2016

Lawsuits against EpiPen maker Mylan moving forward

Milwaukee Journal Sentinel-8 hours ago
pharmacist holds a package of EpiPen epinephrine auto-injector, a Mylan product. (Photo: Rich Pedroncelli, AP). Cincinnati. — The maker of the EpiPen that 

Sydney pharmacist and wholesaler has registration cancelled after ...

dailytelegraph.com.au-20 hours ago
SELLING counterfeit Viagra has landed a Glendenning pharmacist in hot water after the dodgy tablets were distributed to the Sydney Children's Hospital.

Pulling Back the Curtain on Diplomat Pharmacy, Inc. (NYSE:DPLO ...

Engelwood Daily-6 hours ago
Wall Street analysts covering Diplomat Pharmacy, Inc. (NYSE:DPLO) shares are predicting that the stock will trade between $14 and $23 within the next year.

MILITARY UPDATE: Point-of-service controls keeping Rx savings on ...

The Northwest Florida Daily News-9 hours ago
The Department of Defense pharmacy program is on to track to slice $1.3 billion off projected drug costs from 2014 to 2019, thanks to higher beneficiary co-pays, ..